Deals
Bayer to unveil plan to sell plastics business: WSJ Deutschland
Bayer (BAYGn.DE) plans to sell its plastics business with an estimated value of about 8 billion euros ($10.3 billion) as part of a shift away from chemicals toward pharmaceuticals and crop science, a German newspaper reported, citing informed sources.
Activist investor Peltz wants DuPont to break up: WSJ
Activist investor Nelson Peltz's Trian Fund Management has called for a break up of DuPont (DD.N), arguing that the diversified chemicals company's overly complex and bloated corporate structure overburdens its seven business lines, the Wall Street Journal reported.
Endo offers to buy Auxilium Pharma for about $2.2 billion
Specialty healthcare company Endo International Plc (ENDP.O) (ENL.TO) offered to buy Auxilium Pharmaceuticals Inc (AUXL.O) for about $2.2 billion in cash and stock to expand its men's healthcare products business.
Top investors push Salix to abandon Cosmo deal - sources
Some of the top 20 investors at Salix Pharmaceuticals Ltd (SLXP.O) are threatening to vote down a proposed deal to buy a unit of Cosmo Pharmaceuticals SpA (COPN.S), and are pressing Salix to consider selling itself instead, people familiar with the matter said on Tuesday.